Robert E. Reiter
Corporate Officer/Principal bei Jonsson Comprehensive Cancer Center
Profil
Robert E.
Reiter is the founder of ImaginAb, Inc. which was founded in 2007.
He is currently the Director-Genitourinary Cancer Program at Jonsson Comprehensive Cancer Center and a Professor-Urology & Molecular Biology at David Geffen School of Medicine.
Dr. Reiter received his undergraduate degree from Yale University and his doctorate from Stanford University School of Medicine.
Aktive Positionen von Robert E. Reiter
| Unternehmen | Position | Beginn |
|---|---|---|
| Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | - |
| David Geffen School of Medicine | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Robert E. Reiter
| Unternehmen | Position | Ende |
|---|---|---|
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Gründer | - |
Ausbildung von Robert E. Reiter
| Yale University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
| Jonsson Comprehensive Cancer Center |
